AN UPDATED REVIEW ON GLOBAL PHARMACEUTICAL FORMULATION DEVELOPMENTS AND FUTURE POTENTIAL OF NON-INVASIVE TRANSDERMAL DRUG DELIVERY SYSTEM

Background: Over the last several years, there has been much research into the development and modification of new pharmaceutical substances. We have also been able to attain the newest in transdermal drug delivery system treatment with existing pharmaceuticals. We have successfully implemented numerous drug regimens with transdermal delivery systems as one of the most significant developments, offering numerous advantages. Main Body: The distribution of drugs takes place in a detached dose form from the skin-adhesive devices or patches by diffusing throughout the layer of skin to reach out systemic circulation. The worldwide market for transdermal drug delivery systems was reached United States Dollar 4,200.3 Million in 2016 with a predictable increase of compound annual growth rate at 7.5% over the estimated time (2017-2024). The factors like growth and increasing geriatric population in the chronic disease across the globe are promoting the development of the transdermal drug delivery market. Conclusion: We will examine the essential influence of pharmaceutical breakthroughs and the future prospects of non-invasive transdermal drug delivery systems in this review paper, as well as strategies that are being researched to overcome limitations and problems.